5-Lipoxygenase in the Central Nervous System: Therapeutic Implications

E-ISSN： 1875-6131|1|2|115-121

ISSN： 1568-0142

Source： Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol.1, Iss.2, 2002-09, pp. : 115-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physiological Roles of Neurite Outgrowth Inhibitors in Myelinated Axons of the Central Nervous System-Implications for the Therapeutic Neutralization of Neurite Outgrowth Inhibitors

Current Pharmaceutical Design, Vol. 13, Iss. 24, 2007-08 ,pp. : 2529-2537

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines in the Central Nervous System: Targets for Therapeutic Intervention

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 271-280

Bentham Science Publishers

Access to resources Recommend Favorite

New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 148-157

Bentham Science Publishers

Access to resources Recommend Favorite

Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 701-719

Bentham Science Publishers

Access to resources Recommend Favorite

ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-09 ,pp. : 193-210

Bentham Science Publishers

Access to resources Recommend Favorite